Quantification of chemokines by real-time reverse transcriptase PCR: Applications in type 1 diabetes

Expert Review of Molecular Diagnostics

Volumn 6, Issue 1, 2006, Pages 51-64

  Overbergh, Lut ^a   Gysemans, Conny ^a   Mathieu, Chantal ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Chemokines; NOD mice; Real time RT PCR; SYBR Green; TaqMan probes; Type 1 diabetes

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR; GAMMA INTERFERON; GRANZYME B; INTERLEUKIN 1BETA; PERFORIN; RNA; TUMOR NECROSIS FACTOR ALPHA;

BIOPSY; HUMAN; IMMUNOCOMPETENT CELL; IN VITRO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION; REVIEW; SENSITIVITY ANALYSIS;

ANIMALS; CHEMOKINES; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; RECEPTORS, CHEMOKINE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 33645370504     PISSN: 14737159     EISSN: 17448352     Source Type: Journal    
DOI: 10.1586/14737159.6.1.51     Document Type: Review

References (80)

1. Baggiolini M. Chemokines and leukocyte traffic. Nature 392(6676), 565-568 (1998).
2. Ono SJ, Nakamura T, Miyazaki D, Ohbayashi M, Dawson M, Toda M. Chemokines: roles in leukocyte development, trafficking and effector function. J. Allergy Clin. Immunol. 111(6), 1185-1199 (2003).
3. Sallusto F, Mackay CR, Lanzavecchia A. The role of chemokine receptors in primary, effector and memory immune responses. Ann. Rev. Immunol. 18, 593-620 (2000).
4. Ebert LM, Schaerli P, Moser B. Chemokine-mediated control of T cell traffic in lymphoid and peripheral tissues. Mol. Immunol. 42(7), 799-809 (2005).
5. Rossi D, Zlotnik A. The biology of chemokines and their receptors. Ann. Rev. Immunol. 18, 217-242 (2000).
6. Bacon K, Baggiolini M, Broxmeyer H et al. Chemokine/chemokine receptor nomenclature. J. Interferon Cytokine Res. 22(10), 1067-1068 (2002).
7. Soriano SF, Serrano A, Hernanz-Falcon P et al. Chemokines integrate JAK/STAT and G-protein pathways during chemotaxis and calcium flux responses. Eur. J. Immunol. 33(5), 1328-1333 (2003).
8. Coelho AL, Hogaboam CM, Kunkel SL. Chemokines provide the sustained inflammatory bridge between innate and acquired immunity. Cytokine Growth Factor Rev. 16(6), 553-560 (2005).
9. Eizirik DL, Mandrup-Poulsen T. A choice of death - the signal transduction of immune-mediated β-cell apoptosis. Diabetolagia 44, 2115-2133 (2001). Detailed review on mechanisms of cell death.
10. Madiis D, Vence L, Benoist C. β-cell death during progression to diabetes. Nature 414, 792-798 (2001).
11. Cardozo AK, Kruhoffer M, Leeman R, Orntoft T, Eizirik DL. Identification of novel cytokine-induced genes in pancreatic β-cells by high-density oligonucleotide arrays. Diabetes 50(5), 909-920 (2001).
12. Chen MC, Proost P, Gysemans C, Mathieu C, Eizirik DL. Monocyte chemoattractant protein-1 is expressed in pancreatic islets from prediabetic NOD mice and in interleukin-1 β-exposed human and rat islet cells. Diabetolagia 44(3), 325-332 (2001).
13. Chen MC, Schuit F, Eizirik DL. Identification of IL-1 β-induced messenger RNAs in rat pancreatic β cells by differential display of messenger RNA. Diabetologia 42(10), 1199-1203 (1999).
14. Cardozo AK, Heimberg H, Heremans Y et al. A comprehensive analysis of cytokine-induced and nuclear factor-κB-dependent genes in primary rat pancreatic β-cells. J. Biol. Chem. 276(52), 48879-48886 (2001).
15. Kudu B, Darville MI, Cardozo AK, Eizirik DL. Molecular regulation of monocyte chemoattractant protein-1 expression in pancreatic β-cells. Diabetes 52(2), 348-355 (2003).
16. Frigerio S, Junt T, Lu B et al. β cells are responsible for CXCR3-mediated T-cell infiltration in insulitis. Nature Med. 8(12), 1414-1420 (2002). Study showing extensive evidence for a role of CXCL9 and -10 in T-cell-mediated cell loss through the involvement of CXCR3.
17. Arimilli S, Ferlin W, Solvason N, Deshpande S, Howard M, Mocci S. Chemokines in autoimmune diseases. Immunol. Rev. 177, 43-51 (2000).
18. Cameron MJ, Arreaza GA, Grattan M et al. Differential expression of CC chemokines and the CCR5 receptor in the pancreas is associated with progression to type I diabetes. J. Immunol. 165(2), 1102-1110 (2000).
19. Gysemans CA, Cardozo AK, Callewaert H et al. 1,25-dihydroxyvitamin D3 modulates expression of chemokines and cytokines in pancreatic islets: implications for prevention of diabetes in nonobese diabetic mice. Endocrinology 146(4), 1956-1964 (2005).
20. Bertuzzi F, Marzorati S, Maffi P et al. Tissue factor and CCL2/monocyte chemoattractant protein-1 released by human islets affect islet engraftment in type 1 diabetic recipients. J. Clin. Endocrinol. Metab. 89(11), 5724-5728 (2004).
21. Atkinson MA, Leiter EH. The NOD mouse model of type 1 diabetes mellitus: as good as it gets? Nature Med. 5, 601-604 (1999).
22. Bradley LM, Asensio VC, Schioetz LK et al. Islet-specific Th1, but not Th2, cells secrete multiple chemokines and promote rapid induction of autoimmune Diabetes J. Immunol. 162(5), 2511-2520 (1999).
23. Kim SH, Cleary MM, Fox HS, Chantry D, Sarvetnick N. CCR4-bearing T cells participate in autoimmune diabetes. J. Clin. Invest. 110(11), 1675-1686 (2002). Study demonstrating the role of different chemokines expressed in pancreatic islets, in the recruitment of effector T-cells and diabetes development.
24. + T cells. J. Exp. Med. 197(5), 643-656 (2003).
25. + splenocytes that delays adoptive transfer of diabetes expresses L-selectin and high levels of CCR7. J. Immunol. 169(5), 2461-2465 (2002).
26. Grattan M, Mi QS, Meagher C, Delovitch TL. Congenic mapping of the diabetogenic locus Idd4 to a 5.2-cM region of chromosome 11 in NOD mice: identification of two potential candidate subloci. Diabetes 51(1), 215-223 (2002).
27. Ohashi PS, Oehen S, Buerki K et al. Ablation of 'tolerance' and induction of diabetes by virus infection in viral antigen transgenic mice. Cell 65(2), 305-317 (1991).
28. Giarratana N, Penna G, Amuchastegui S, Mariani R, Daniel KC, Adorini L. A vitamin D analog downregulates pro-inflammatory chemokine production by pancreatic islets inhibiting T cell recruitment and type 1 diabetes development. J. Immunol. 173(4), 2280-2287 (2004).
29. Cardozo AK, Proost P, Gysemans C, Chen MC, Mathieu C, Eizirik DL. IL-1β and IFN-γ induce the expression of diverse chemokines and IL-15 in human and rat pancreatic islet cells, and in islets from pre-diabetic NOD mice. Diabetologia 46(2), 255-266 (2003). Comparative study between human and rodent islets on chemokine expression, as identified by real-time reverse transcriptase (RT) PCR.
30. Schroppel B, Zhang N, Chen P, Chen D, Bromberg JS, Murphy B. Role of donor-derived monocyte chemoattractant protein-1 in murine islet transplantation. J. Am. Soc. Nephrol. 16(2), 444-451 (2005).
31. Grewal IS, Rutledge BJ, Fiorillo JA et al. Transgenic monocyte chemoattractant protein-1 (MCP-1) in pancreatic islets produces monocyte-rich insulitis without diabetes: abrogation by a second transgene expressing systemic MCP-1. J. Immunol. 159(1), 401-408 (1997).
32. Morimoto J, Yoneyama H, Shimada A et al. CXC chemokine ligand 10 neutralization suppresses the occurrence of diabetes in nonobese diabetic mice through enhanced β cell proliferation without affecting insulitis. J. Immunol. 173(11), 7017-7024 (2004).
33. Christen U, Von Herrath MG. IP-10 and type 1 diabetes: a question of time and location. Autoimmunity 37(5), 273-282 (2004).
34. Rhode A, Pauza ME, Barral AM et al. Islet-specific expression of CXCL10 causes spontaneous islet infiltration and accelerates diabetes development. J. Immunol. 175(6), 3516-3524 (2005).
35. Baker MS, Chen X, Rotramel AR et al. Genetic deletion of chemokine receptor CXCR3 or antibody blockade of its ligand IP-10 modulates posttransplantation graft-site lymphocytic infiltrates and prolongs functional graft survival in pancreatic islet allograft recipients. Surgery 134(2), 126-133 (2003).
36. Baker MS, Chen X, Rotramel AR, Nelson JJ, Kaufman DB. Interferon regulatory factor-1 downregulates cytokine-induced IP-10 expression in pancreatic islets. Surgery 34(2), 134-141 (2003).
37. Shimada A, Morimoto J, Kodama K et al. Elevated serum IP-10 levels observed in type 1 Diabetes. Diabetes Care 24(3), 510-515 (2001).
38. Nicoletti F, Conget I, Di Mauro M et al. Serum concentrations of the interferon-γ-inducible chemokine IP-10/CXCL10 are augmented in both newly diagnosed type I diabetes mellitus patients and subjects at risk of developing the disease. Diabetologia 45(8), 1107-1110 (2002).
39. Lohmann T, Laue S, Nietzschmann U et al. Reduced expression of Th1-associated chemokine receptors on peripheral blood lymphocytes at diagnosis of type 1 diabetes Diabetes 51(8), 2474-2480 (2002).
40. Nomura S, Shouzu A, Omoto S, Nishikawa M, Fukuhara S. Significance of chemokines and activated platelets in patients with diabetes. Clin. Exp. Immunol. 121(3), 437-443 (2000).
41. Dubois-Laforgue D, Hendel H, Caillat-Zucman S et al. A common stromal cell-derived factor-1 chemokine gene variant is associated with the early onset of type 1 diabetes. Diabetes 50(5), 1211-1213 (2001).
42. Ide A, Kawasaki E, Abiru N et al. Stromal cell-derived factor-1 chemokine gene variant is associated with type 1 diabetes age at onset in Japanese population. Hum. Immunol. 64(10), 973-978 (2003).
43. Buhler MM, Craig M, Donaghue KC et al. CCR5 genotyping in an Australian and New Zealand type 1 diabetes cohort. Autoimmunity 35(7), 457-461 (2002).
44. Szalai C, Csaszar A, Czinner A et al. Chemokine receptor CCR2 an CCR5 polymorphisms in children with insulin-dependent diabetes mellitus. Pediatr. Res. 46(1), 82-84 (1999).
45. Yang B, Houlberg K, Millward A, Demaine A. Polymorphisms of chemokine and chemokine receptor genes in type 1 diabetes mellitus and its complications. Cytokine 26(3), 114-121 (2004).
46. Matos M, Park R, Mathis D, Benoist C. Progression to islet destruction in a cyclophosphamide-induced transgenic model: a microarray overview. Diabetes 53(9), 2310-2321 (2004).
47. Bouma G, Coppens JM, Lam-Tse WK et al. An increased MRP8/14 expression and adhesion, but a decreased migration towards pro-inflammatory chemokines of type 1 diabetes monocytes. Clin. Exp. Immunol. 141(3), 509-517 (2005).
48. Bouma G, Coppens JM, Mounts S et al. Evidence for an enhanced adhesion of DC to fibronectin and a role of CCL19 and CCL21 in the accumulation of DC around the pre-diabetic islets in NOD mice. Eur. J. Immunol. 35(8), 2386-2396 (2005).
49. Christen U, McGavern DB, Luster AD, von Herrath MG, Oldstone MB. Among CXCR3 chemokines, IFN-γ-inducible protein of 10 kDa (CXC chemokine ligand (CXCL) 10) but not monokine induced by IFN-γ (CXCL9) imprints a pattern for the subsequent development of autoimmune disease. J. Immunol. 171(12), 6838-6845 (2003).
50. + clones associated with IFN-γ-inducible protein 10 (CXC chemokine ligand 10) production but not cytokine expression, cytolytic activity, or homing characteristics. J. Immunol. 174(5), 2746-2755 (2005).
51. Kayali AG, Van Gunst K, Campbell IL et al. The stromal cell-derived factor-1α/CXCR4 ligand-receptor axis is critical for progenitor survival and migration in the pancreas. J. Cell Biol. 163(4), 859-869 (2003).
52. Mahajan SD, Schwartz SA, Nair MP. Immunological assays fo chemokine detection in in vitro culture of CNS cells. Biol. Proced. Online 5, 90-102 (2003).
53. Heid CA, Stevens J, Livak KJ, Williams PM. Real time quantitative PCR. Genome Res. 6(10), 986-994 (1996). First article describing the principle of real-time PCR in detail.
54. Higuchi R, Dollinger G, Walsh PS, Griffith R. Simultaneous amplification and detection of specific DNA sequences. Biotechnology 10, 413-417 (1992).
55. Overbergh L, Giulietti A, Valckx D, Decallonne R, Bouillon R, Mathieu C. The use of real-time reverse transcriptase PCR for the quantification of cytokine gene expression. J. Biomol. Tech. 14(1), 33-43 (2003).
56. Silva TA, Garlet GP, Lara VS, Martins W Jr, Silva JS, Cunha FQ. Differential expression of chemokines and chemokine receptors in inflammatory periapical diseases. Oral Microbiol. Immunol. 20, 310-316 (2005).
57. Carvalho-Gaspar M, Billing JS, Spriewald BM, Wood KJ. Chemokine gene expression during allograft rejection: comparison of two quantitative PCR techniques. J. Immunol. Methods 301, 41-52 (2005).
58. Holland PM, Abramson RD, Watson R, Gelfand DH. Detection of specific polymerase chain reaction product by utilizing the 5′-3′ exonuclease activity of Thermus aquaticus DNA polymerase. Proc. Natl Acad. Sci. USA 88(16), 7276-7280 (1991).
59. Wittwer CT, Herrmann MG, Moss AA, Rasmussen RP. Continuous fluorescence monitoring of rapid cycle DNA amplification. Biotechniques 22, 130-131, 134-138 (1997).
60. Giulietti A, Overbergh L, Valckx D, Decallonne B, Bouillon R, Mathieu C. An overview of real-time quantitative PCR: applications to quantify cytokine gene expression. Methods 25(4), 386-401 (2001). Extensive review of real-time RT-PCR, including a large list of optimized primer sets for cytokine assays.
61. Kutyavin IV, Afonina IA, Mills A et al. 3′ minor groove binder-DNA probes increase sequence specificity at PCR extension temperatures. Nucleic Acids Res. 28(2), 655-661 (2000).
62. Belousov YS, Welch RA, Sanders S et al. Single nucleotide polymorphism genotyping by two-colour melting curve analysis using the MGB Eclipse Probe System in challenging sequence environment. Hum. Genomics. 1, 209-217 (2004).
63. Bernard PS, Wittwer CT. Homogeneous amplification and variant detection by fluorescent hybridization probes. Clin. Chem. 46(2), 147-148 (2000).
64. Tyagi S, Kramer FR. Molecular beacons: probes that fluoresce upon hybridization. Nature Biotechnol. 14(3), 303-308 (1996).
65. Letertre C, Perelle S, Dilasser F, Arar K, Fach P. Evaluation of the performance of LNA and MGB probes in 5′-nuclease PCR assays. Mol. Cell Probes 17(6), 307-311 (2003).
66. Svanvik N, Stahlberg A, Sehlstedt U, Sjoback R, Kubista M. Detection of PCR products in real time using light-up probes. Anal. Biochem. 287(1), 179-182 (2000).
67. Whitcombe D, Theaker J, Guy SP, Brown T, Little S. Detection of PCR products using self-probing amplicons and fluorescence. Nature Biotechnol. 17, 804-807 (1999).
68. Ririe KM, Rasmussen RP, Wittwer CT. Product differentiation by analysis of DNA melting curves during the polymerase chain reaction. Anal. Biochem. 245(2), 154-160 (1997).
69. Rozen S, Skaletsky H. PrimeR3 on the WWW for general users and for biologist programmers. Methods Mol. Biol. 132, 365-386 (2000).
70. Breslauer KJ, Frank R, Blocker H, Marky LA. Predicting DNA duplex stability from the base sequence. Proc. Natl Acad. Sci. USA 83(11), 3746-3750 (1986).
71. Bustin SA, Nolan T. Pitfalls of quantitative real-time reverse-transcription polymerase chain reaction. J. Biomol. Tech. 15, 155-166 (2004).
72. Huggett J, Dheda K, Bustin S, Zumla A. Real-time RT-PCR normalisation; strategies and considerations. Genes Immun. 6, 279-284 (2005).
73. van der Velden VH, Boeckx N, van Wering ER, van Dongen JJ. Detection of minimal residual disease in acute leukemia. J. Biol. Regul. Homeost. Agents 18, 146-154 (2004).
74. Stahlberg A, Hakansson J, Xian X, Semb H, Kubista M. Properties of the reverse transcription reaction in mRNA quantification. Clin. Chem. 50(3), 509-515 (2004).
75. Stahlberg A, Kubista M, Pfaffl M. Comparison of reverse transcriptases in gene expression analysis. Clin. Chem. 50(9), 1678-1680 (2004).
76. Bustin SA. Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J. Mol. Endocrinol. 25(2), 169-193 (2000).
77. Vandesompele J, De Preter K, Pattyn F et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 3(7), RESEARCH0034 (2002). Describes a method for identifying a relevant housekeeping gene.
78. Szabo A, Perou CM, Karaca M, Perreard L, Quackenbush JF, Bernard PS. Statistical modeling for selecting housekeeper genes. Genome Biol. 5(8), R59 (2004).
79. Akilesh S, Shaffer DJ, Roopenian D. Customized molecular phenotyping by quantitative gene expression and pattern recognition analysis. Genome Res. 13(7), 1719-1727 (2003).
80. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29(9), e45 (2001). Describes a new mathematical method for relative quantification, which take PCR efficiency into account.